Publications
Liefaard L.C., Ploeger B.A., Molthoff C.F., Boellaard R., Lammertsma A.A., Danhof M. and Voskuyl R.A., Population pharmacokinetic analysis for simultaneous determination of B (max) and K (D) in vivo by positron emission tomography, Mol Imaging Biol., 7(6): 411-421., 2005. [Link to publication]
Swart E.L., Zuideveld K.P., Jongh J.d., Danhof M., Thijs L.G. and Strack van Schijndel R.M., Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients, Br J Clin Pharmacol., 57(2): 135-145., 2004. [Link to publication]
Schaddelee M.P., Groenendaal D., Jongh J.d., Cleypool C.G., AP I.J., Boer A.G. d. and Danhof M., Population pharmacokinetic modeling of blood-brain barrier transport of synthetic adenosine A1 receptor agonists, J Pharmacol Exp Ther, 311(3): 1138-1146, 2004. [Link to publication]
Schaddelee M.P., Jongh J.d., Collins S.D., Boer A.G.d., Ijzerman A.P. and Danhof M., Population pharmacokinetic-pharmacodynamic modelling of the anti-hyperalgesic effect of 5’deoxy-N6-cylopentyladenosine in the mononeuropathic rat, Eur J Pharmacol, 504(1-2): 7-15, 2004. [Link to publication]
Knibbe C.A., Zuideveld K.P., Jongh J.d., Kuks P.F., Aarts L.P. and Danhof M. , Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%, Clin Pharmacol Ther. , 72 : 670-84., 2002. [Link to publication]
- « Previous
- 1
- …
- 11
- 12
- 13